Identification and localization of a tau peptide to paired helical filaments of Alzheimer disease - PubMed (original) (raw)

Identification and localization of a tau peptide to paired helical filaments of Alzheimer disease

K Iqbal et al. Proc Natl Acad Sci U S A. 1989 Jul.

Abstract

Amino acid sequencing of a CNBr digest of the tau protein isolated from bovine brain revealed an amino acid sequence of 17 residues, Pro-Gly-Leu-Lys-Glu-Ser-Pro-Leu-Gln-Ile-Gly-Ala-Ala-Pro-Gly-Leu-Lys, which we call peptide I, with heterogeneity at position 11 of glycine (peptide Ia) and proline (peptide Ib); peptide I showed no homology with the previously reported cDNA-derived mouse and human tau sequences. Antisera raised to synthetic peptides corresponding to peptides Ia and Ib labeled all the bovine tau polypeptides recognized by other monoclonal and polyclonal antibodies to bovine tau. Antisera to peptide Ib did not label any mouse tau polypeptides; however, an anti-Ia antiserum labeled two of the four mouse tau polypeptides. Antisera to both peptides labeled paired helical filaments (PHF) as neurofibrillary tangles, plaque neurites, and neuropil threads in Alzheimer disease brain and PHF polypeptides on immunoblots. Immunostaining with anti-Ia antisera of PHF in tissue sections and PHF polypeptides, but not bovine tau, on immunoblots was markedly increased when pretreated with alkaline phosphatase. These studies suggest that (i) the amino acid sequences of some isoforms of tau peptide might be different from that predicted from cDNAs, (ii) a tau peptide that is absent in the predicted sequences is present in PHF in Alzheimer disease, and (iii) tau in PHF is abnormally phosphorylated.

PubMed Disclaimer

Similar articles

• Microtubule-associated polypeptides tau are altered in Alzheimer paired helical filaments.
  Grundke-Iqbal I, Vorbrodt AW, Iqbal K, Tung YC, Wang GP, Wisniewski HM. Grundke-Iqbal I, et al. Brain Res. 1988 Aug;464(1):43-52. doi: 10.1016/0169-328x(88)90017-4. Brain Res. 1988. PMID: 3141008
• Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology.
  Grundke-Iqbal I, Iqbal K, Tung YC, Quinlan M, Wisniewski HM, Binder LI. Grundke-Iqbal I, et al. Proc Natl Acad Sci U S A. 1986 Jul;83(13):4913-7. doi: 10.1073/pnas.83.13.4913. Proc Natl Acad Sci U S A. 1986. PMID: 3088567 Free PMC article.
• Protein TAU variants present in paired helical filaments (PHFs) of Alzheimer brains.
  Gache Y, Ricolfi F, Guilleminot J, Theiss G, Nunez J. Gache Y, et al. FEBS Lett. 1990 Oct 15;272(1-2):65-8. doi: 10.1016/0014-5793(90)80450-w. FEBS Lett. 1990. PMID: 2121538
• Molecular pathology of Alzheimer neurofibrillary degeneration.
  Iqbal K, Alonso A, Gong C, Khatoon S, Kudo T, Singh T, Grundke-Iqbal I. Iqbal K, et al. Acta Neurobiol Exp (Wars). 1993;53(1):325-35. Acta Neurobiol Exp (Wars). 1993. PMID: 8317268 Review.
• Molecular dissection of the paired helical filament.
  Goedert M, Spillantini MG, Jakes R, Crowther RA, Vanmechelen E, Probst A, Götz J, Bürki K, Cohen P. Goedert M, et al. Neurobiol Aging. 1995 May-Jun;16(3):325-34. doi: 10.1016/0197-4580(95)00017-9. Neurobiol Aging. 1995. PMID: 7566342 Review.

Cited by

• Regulation of tau internalization, degradation, and seeding by LRP1 reveals multiple pathways for tau catabolism.
  Cooper JM, Lathuiliere A, Migliorini M, Arai AL, Wani MM, Dujardin S, Muratoglu SC, Hyman BT, Strickland DK. Cooper JM, et al. J Biol Chem. 2021 Jan-Jun;296:100715. doi: 10.1016/j.jbc.2021.100715. Epub 2021 Apr 28. J Biol Chem. 2021. PMID: 33930462 Free PMC article.
• Tau in Alzheimer disease and related tauopathies.
  Iqbal K, Liu F, Gong CX, Grundke-Iqbal I. Iqbal K, et al. Curr Alzheimer Res. 2010 Dec;7(8):656-64. doi: 10.2174/156720510793611592. Curr Alzheimer Res. 2010. PMID: 20678074 Free PMC article. Review.
• Alzheimer neurofibrillary degeneration: therapeutic targets and high-throughput assays.
  Iqbal K, Alonso Adel C, El-Akkad E, Gong CX, Haque N, Khatoon S, Pei JJ, Tanimukai H, Tsujio I, Wang JZ, Grundke-Iqba I. Iqbal K, et al. J Mol Neurosci. 2003;20(3):425-9. doi: 10.1385/jmn:20:3:425. J Mol Neurosci. 2003. PMID: 14501027 Review.
• Pyridoxamine and Aminoguanidine Attenuate the Abnormal Aggregation of β-Tubulin and Suppression of Neurite Outgrowth by Glyceraldehyde-Derived Toxic Advanced Glycation End-Products.
  Ooi H, Nasu R, Furukawa A, Takeuchi M, Koriyama Y. Ooi H, et al. Front Pharmacol. 2022 Jun 3;13:921611. doi: 10.3389/fphar.2022.921611. eCollection 2022. Front Pharmacol. 2022. PMID: 35721214 Free PMC article.
• Evaluation of GammaH2AX in Buccal Cells as a Molecular Biomarker of DNA Damage in Alzheimer's Disease in the AIBL Study of Ageing.
  Siddiqui MS, Francois M, Rainey-Smith S, Martins R, Masters CL, Ames D, Rowe CC, Macaulay LS, Fenech MF, Leifert WR. Siddiqui MS, et al. Life (Basel). 2020 Aug 6;10(8):141. doi: 10.3390/life10080141. Life (Basel). 2020. PMID: 32781776 Free PMC article.

References

1. 1. Nature. 1970 Aug 15;227(5259):680-5 - PubMed
2. 1. Mol Cell Biol. 1989 Apr;9(4):1381-8 - PubMed
3. 1. Brain Res. 1974 Sep 6;77(2):337-43 - PubMed
4. 1. Proc Natl Acad Sci U S A. 1975 May;72(5):1858-62 - PubMed
5. 1. J Mol Biol. 1977 Oct 25;116(2):207-25 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Europe PubMed Central
  • PubMed Central

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information

• Miscellaneous

  • NCI CPTAC Assay Portal